Pharmacogenomic considerations in opioid analgesia. [Corrigendum]
Authors Vuilleumier PH, Stamer UM, Landau R
Received 20 September 2012
Accepted for publication 20 September 2012
Published 14 January 2013 Volume 2013:6 Pages 1—2
Vuilleumier PH, Stamer UM, Landau R. Pharmacogenomic considerations in opioid analgesia. Pharmacogenomics and Personalized Medicine. 2012;5:73–87.
The authors regret an error in their Figure 1, CYP metabolism involved in opioid clearance.
Read the original article
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]